M yxomas are the most common primary cardiac tumor and are located in the left atrium about 75% of the time. Th romboembolic events, obstruction to blood fl ow, and constitutional symptoms form the classic triad in patients with cardiac myxoma. Recurrence is rarely described, mainly in the context of familial syndromes. Such was the case in the patient reported herein.
CASE REPORT
A 38-year-old woman had surgical excision of a right atrial myxoma in March 2008 and excision of a recurrence in August 2012. She presented again with exertional dyspnea. There were no precordial murmurs. An electrocardiogram revealed sinus rhythm with right atrial overload. A radiograph showed clear lung fields with no cardiomegaly. An echocardiogram showed a pedunculated mass of 4.9 × 4 cm in the right atrium with attachment to the atrial septum, obstructing the right ventricular inflow (Figure 1) . A coronary angiogram was normal. The patient underwent surgical excision of the right atrial tumor for the third time in December 2014 ( Figure 2 ). Histopathologic examination confirmed the diagnosis of myxoma (Figure 3) . A follow-up echocardiogram did not reveal any residual mass, and the patient was asymptomatic at 5-month follow-up.
DISCUSSION
Primary cardiac tumors are extremely rare, with an autopsy incidence ranging from 0.001% to 0.33%. Most cardiac tumors are benign, with atrial myxoma accounting for 30% to 50% of cases. Among the atrial myxomas, <25% arise from the right atrium, and the most common site of origin is the interatrial septum (1) . Th e recurrence rate of sporadic myxoma is 2% to 3% (2). Gerbode et al described the fi rst case of myxoma recurrence, which occurred several years after surgical removal. Recurrence is usually seen during the fi rst 3 to 4 years, although it can emerge within a few months to several years after surgical excision. Th e recurrence rate is 22% in patients with Carney complex (3), a complex of myxomas, spotty skin pigmentation, and endocrine overactivity. Although the mechanism of recurrence is diffi cult to confi rm in an individual case, the possibility of a familial syndrome should always be considered. Th e presence of concurrent cardiac lesions and clinical features suggestive of Carney complex (such as spotty skin pigmentation, endocrine disease, or benign extracardiac connective tissue tumors) should raise the suspicion of familial transmission, for which causative mutations have been identifi ed. Almost 60% of patients with known Carney complex have an inactivating mutation in the PRKAR1A gene, which codes for the regulatory subunit type 1α of the cAMP-dependent protein kinase A, located on chromosome 17q23-24 (4), leading to aberrant function of protein kinase A and increased phosphorylation of targets concerned with cell transcription, metabolism, cell cycle progression, and apoptosis (5) . Th e PRKAR1A gene seemingly functions as a tumor suppressor gene in tumors of Carney complex patients.
Th e possible causes of tumor recurrence include incomplete resection, implantation of tumor cells during tumor excision, and
